- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/85 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Patent holdings for IPC class C07D 307/85
Total number of patents in this class: 156
10-year publication summary
|
9
|
16
|
10
|
8
|
13
|
11
|
5
|
17
|
10
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Pharmacyclics LLC | 240 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2853 |
6 |
| Bayer AG | 3331 |
5 |
| Cancer Research Technology Limited | 523 |
5 |
| Enyo Pharma | 57 |
5 |
| Isosterix, Inc. | 7 |
5 |
| Merck Patent GmbH | 5823 |
4 |
| Abbvie Inc. | 1801 |
4 |
| The Broad Institute, Inc. | 1818 |
4 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
4 |
| Calico Life Sciences LLC | 96 |
4 |
| F. Hoffmann-La Roche AG | 7921 |
3 |
| Bionomics Limited | 88 |
3 |
| Symed Labs Limited | 52 |
3 |
| University of Kansas | 873 |
3 |
| Vanderbilt University | 1904 |
3 |
| Nido Biosciences, Inc. | 15 |
3 |
| Novartis AG | 10850 |
2 |
| Boehringer Ingelheim Vetmedica GmbH | 1273 |
2 |
| Janssen Pharmaceutica N.V. | 3383 |
2 |
| Other owners | 78 |